Park Circle Company’s GSK GSK Stock Holding History

Park Circle Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-480	Closed	-$20.7K	–	60
2025 Q3	$20.7K	Sell	480 -320	-40%	-$12.5K	0.02%	61
2025 Q2	$30.7K	Hold	800	–	–	0.03%	85
2025 Q1	$31K	Hold	800	–	–	0.03%	84
2024 Q4	$27.1K	Hold	800	–	–	0.02%	82
2024 Q3	$32.7K	Hold	800	–	–	0.03%	78
2024 Q2	$30.8K	Hold	800	–	–	0.03%	82
2024 Q1	$34.3K	Hold	800	–	–	0.03%	82
2023 Q4	$29.6K	Hold	800	–	–	0.03%	92
2023 Q3	$29K	Hold	800	–	–	0.03%	84
2023 Q2	$28.5K	Hold	800	–	–	0.03%	85
2023 Q1	$28.5K	Hold	800	–	–	0.03%	88
2022 Q4	$28.1K	Hold	800	–	–	0.03%	84
2022 Q3	$24K	Hold	800	–	–	0.02%	102
2022 Q2	$44K	Hold	800	–	–	0.04%	98
2022 Q1	$44K	Hold	800	–	–	0.04%	86
2021 Q4	$44K	Hold	800	–	–	0.03%	91
2021 Q3	$38K	Hold	800	–	–	0.03%	92
2021 Q2	$40K	Hold	800	–	–	0.03%	83
2021 Q1	$36K	Sell	800 -32,000	-98%	-$1.45M	0.03%	78
2020 Q4	$1.51M	Buy	32,800 +320	+1%	+$14.7K	1.43%	21
2020 Q3	$1.53M	Buy	32,480 +9,600	+42%	+$481K	1.69%	17
2020 Q2	$1.17M	Hold	22,880	–	–	1.49%	16
2020 Q1	$1.08M	Hold	22,880	–	–	1.31%	17
2019 Q4	$1.34M	Hold	22,880	–	–	0.9%	27
2019 Q3	$1.22M	Hold	22,880	–	–	0.66%	35
2019 Q2	$1.15M	Hold	22,880	–	–	0.78%	27
2019 Q1	$1.2M	Hold	22,880	–	–	0.85%	29
2018 Q4	$1.09M	Hold	22,880	–	–	0.89%	26
2018 Q3	$1.15M	Hold	22,880	–	–	0.72%	36
2018 Q2	$1.15M	Hold	22,880	–	–	0.75%	33
2018 Q1	$1.12M	Buy	22,880 +480	+2%	+$22.4K	0.69%	34
2017 Q4	$993K	Sell	22,400 -13,760	-38%	-$636K	0.55%	35
2017 Q3	$1.83M	Buy	36,160 +480	+1%	+$24.4K	1.05%	30
2017 Q2	$1.92M	Hold	35,680	–	–	1.08%	25
2017 Q1	$1.88M	Buy	35,680 +7,520	+27%	+$381K	1.18%	23
2016 Q4	$1.35M	Buy	28,160 +8,720	+45%	+$431K	0.89%	32
2016 Q3	$1.05M	Sell	19,440 -232	-1%	-$12.7K	0.73%	31
2016 Q2	$1.07M	Hold	19,672	–	–	0.77%	32
2016 Q1	$997K	Hold	19,672	–	–	0.76%	29
2015 Q4	$992K	Sell	19,672 -34,552	-64%	-$1.76M	0.67%	31
2015 Q3	$2.61M	Hold	54,224	–	–	1.72%	18
2015 Q2	$2.82M	Hold	54,224	–	–	1.69%	17
2015 Q1	$3.13M	Buy	54,224 +8,000	+17%	+$459K	2.03%	16
2014 Q4	$2.47M	Buy	46,224 +9,280	+25%	+$519K	1.44%	21
2014 Q3	$2.12M	Buy	36,944 +944	+3%	+$57.9K	1.34%	22
2014 Q2	$2.41M	Buy	36,000 +16,000	+80%	+$1.08M	1.61%	18
2014 Q1	$1.34M	Buy	+20,000	New	+$1.35M	0.99%	24

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Park Circle Company's GSK Position: Q4 2025 in Review

Park Circle Company sold out of GSK (GSK) in Q4 2025, closing a stake of 480 shares — an estimated $20.7K sold.

Park Circle Company first reported a position in GSK in Q1 2014 and held it in 47 quarters. The position peaked at $3.13M in Q1 2015. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Park Circle Company reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
Park Circle Company sold 480 GSK shares in Q4 2025, an estimated $20.7K.
Park Circle Company first reported a position in GSK in Q1 2014 and held it in 47 quarters.
Park Circle Company's GSK position peaked at $3.13M in Q1 2015.
995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Park Circle Company's 13F filing for Q4 2025, filed 13 Feb 2026.